The case of the GMO papaya: How does it relate to the Prop 37 fight?

Until Californians go to the ballot box on Nov. 6, rhetoric from both supporters and opponents of the state’s Proposition 37 will only continue to intensify. Both viewpoints, however, share some common ground on at least one important point: The best way to persuade members of the voting public is by framing the debate based on what consumers want the most—is it an issue of price, of information, of safety, or of some other characteristic that consumers may weigh when making a purchase?

Perhaps another way to approach the GMO debate would be to step out of our own shoes for a moment and consider the viewpoints of some of the crops that we depend upon and enjoy.

No, seriously.

Very often, biotechnology firms attempt to market GMO products with claims that they offer some benefit to the consumer and grower, e.g., higher nutrient density, higher yields, pest resistance. In other cases, however, something as vital as a crop’s continued survival may depend on transgenesis.

View the original article here: The case of the GMO papaya

New gene-therapy approach could improve obesity treatment

x
Medical researchers at the University of Alberta have found a new way of using gene therapy to treat obesity. The treatment was successful, resulting in less weight gain, higher activity levels and decreased insulin resistance in lab models on a high-fat, high-sugar diet. Faculty of Medicine & Dentistry researcher Jason Dyck, who works in the Department of Pediatrics and the Department of Pharmacology, published his findings this week in the peer-reviewed journal Nutrition and Diabetes. His team found a way to deliver the obesity treatment via DNA as opposed to a virus, which has had limited success in the past, especially over the long term. The results they demonstrated corroborated findings by other researchers who conducted short-term studies or used more risky methods of gene delivery.

View the original article here: New gene-therapy approach could improve obesity treatment – Medical Xpress

Cord blood-derived stem cells: New therapeutic option for brain disorders?

ae x

Stem cell technology has the potential to revolutionize medicine, but the revolution has been considerably slower than expected. Government restrictions and ethical dilemmas have put up roadblocks to fast-paced biological research, and even when these roadblocks are absent, controlling the behavior of stem cells (cells that have the ability to form a number of cell types and tissues) in a petri dish has proved tricky to say the least.

In one particular area of stem cell research, however, progress has been steady. Cord blood stem cells can be harvested from the umbilical cord and placenta of a newborn baby and stored for future use, the idea being that they can be used down the road should that baby (or a genetically similar relative) become sick. These stem cells have been used to treat close to 100 blood-based conditions, including several types of leukemia.

View the original article here: Cord Blood-Derived Stem Cells – a New Therapeutic Option for Brain Disorders? – Brain Blogger (blog)

Genetic Information Nondiscrimination Act passes House of Representatives

The House of Representatives passed the Genetic Information Nondiscrimination Act (GINA) of 2007 on Wednesday, April 25. GINA is expected to pass the Senate and be signed into law in the coming months.

Despite widespread, longstanding agreement among American citizens and politicians that protection from genetic discrimination should be clear and consistent, individuals’ genetic information has, to this point, been protected only by a largely untested patchwork of state and federal regulations. Ninety-two percent of Americans are concerned that results of a genetic test that tells a patient whether he or she is at increased risk for a disease like cancer could be used in ways that are harmful to the person, and most believe that employers and health insurers should not have access to this information.

View the original article here: Genetic Information Nondiscrimination Act Passes House, USA …

Research reveals that genetics may play a role in how people behave during a crisis

Many people may wonder how they would react in an emergency situation, one that could involve risking their lives to save others.

Incidents like a man saving a Brooklyn girl as she fell out of a window, a bus driver swerving to protect passengers in a crash and a woman diving into traffic to save a pair of children may be the result of genetics, according to new research.

Experts told CBS 2′s Maurice Dubois on Wednesday that not everyone is capable of making these split-second decisions.

“First, of course, there is a genetic component,” said Dr Igor Galynker of Beth-Israel Medical Center. “They are capable of acting decisively, impulsively under any circumstances.”

View the original article here: Research Reveals Genetics May Play Role In How People Act In …

Stem cells do decline with aging, scientists’ finding confirmed

The ageing process adversely affects the quantity of the bone marrow stem cells, was the finding by the Indo-Japan joint working group of NCRM published in Bone Marrow Research. However, an earlier study by Posvic et al., which had claimed that the stem cells of bone marrow don’t decline with ageing, has been questioned by the NCRM group based on their own findings. The NCRM group has given a thorough explanation reiterating the logic behind their findings, which has been published in the Journal of Gerontology, the official issue of the Gerontological Society of America.

The author of the article Dr Abraham, has explained that their findings in more than 300 people of various age groups have proven that stem cells decrease in quantity with ageing and any generalisation of a fact in contrary can be acceptable only when evaluated in larger number of healthy age matched controls without any comorbidity.

View the original article here: Stem cells do decline with aging, Chennai scientists’ finding reiterated – Express Pharma

Prop. 37: Another example of the perils of the initiative process?

prop label

Love it or hate it, the one thing you can say for sure about California’s ballot initiative process is that it’s the absolute worst way to craft policy dealing with complex scientific issues.

That doesn’t stop advocates on one side or another from constantly trying, with the result that the public’s understanding of the underlying facts plummets faster than you can say, well, “Proposition 37.”

Proposition 37 is on November’s ballot. The measure would require some, but not all, food sold in California and produced via genetic engineering to be labeled as such. (There are exemptions for milk, restaurant food and other products.)

Genetic engineering, or genetic modification, which involves manipulating DNA or transferring it from one species to another, is increasingly common in agriculture and food processing, and wouldn’t be banned or even regulated by the measure. Genetic engineering has pluses and minuses. It can increase crop yields and pest resistance. But it can also affect the environment in negative ways — pollen or seeds from genetically engineered crops can be spread by wind, birds or insects to territory where they’re unwanted, for example.

View the original article here: Prop. 37: Another example of the perils of the initiative process?

Scientists savage study purportedly showing health dangers of Monsanto’s GM corn

corn husks

Are GM foods harmful or nutritionally less beneficial when compared to conventional or organic foods? Scientists and regulators almost universally say “no.” That’s why a study published this week claiming that GM corn causes cancer in rats is creating such a furor. What’s the story behind the story? Jon Entine, executive director of the Genetic Literacy Project, reports.

Does Monsanto’s Roundup Ready corn (Europeans call it maize) cause health problems? It’s a reasonable question. It’s been asked and answered, at least to the satisfaction of most researchers.

View the original article here: Scientists savage study purportedly showing health dangers of Monsanto’s genetically modified corn

Sorghum eyed as a southern bioenergy crop

Sorghum is an ideal candidate because of its drought tolerance, adaptability to diverse growing conditions, low nitrogen fertilizer requirements, and high biomass (plant material) content, according to molecular biologist Scott Sattler and collaborator Jeff Pedersen with USDA’s Agricultural Research Service (ARS). It also produces soluble sugar that can be converted to biofuel. Residual fibers left over from the juice extraction process also can be burned to generate electricity. Sattler and Pedersen’s studies of sorghum are part of a larger effort by ARS—USDA’s principal intramural scientific research agency—to answer a government mandate calling for the production of up to 36 billion gallons of biofuel by 2022. Approximately 15 billion gallons of that total will come from grain ethanol, with the remaining 21 billion gallons to come from other sources, or “feedstocks,” including sorghum, sugarcane, other grasses like switchgrass, and oilseed crops like rapeseed and soybean.

View the original article here: Sorghum eyed as a southern bioenergy crop

Meet the world’s first transhumanist politician

It’s not necessarily a negative thing for us to become less human, says transhumanist politician Giuseppe Vatinno.

What is transhumanism?
Transhumanism is a philosophical doctrine that aims to continuously improve humanity. It promotes science and technology but with people at its centre. Ultimately, it aims to free humanity from its biological limitations, overcoming natural evolution to make us more than human.

How does transhumanism improve humanity?
It does this through the development of technologies that boost health and fight ageing and disease, by replacing lost or defective body parts and by improving the internet, communication technologies and artificial intelligence.

View the original article here: Meet the world’s first transhumanist politician – New Scientist

Genome sequencing of one patient’s tumor could lead to new treatment options

“In mapping the entire genome of a tumor from a patient with advanced bladder cancer, researchers at Memorial Sloan-Kettering have uncovered a genetic weakness that could potentially be targeted with an existing drug. Published in the journal Science on August 21, the findings could lead to new and potent therapies for a subset of patients with the disease.

In addition, the investigators hope that their study might encourage more research on cases in which a cancer drug is shown to work in a small number of patients but further investigation has not been pursued because the treatment was found to be ineffective in the majority of patients.

The findings were made after an early-stage clinical trial in which Memorial Sloan-Kettering physicians treated advanced bladder cancer patients with everolimus (Afinitor®), a targeted therapy already used in the treatment of kidney cancer, among other cancer types. While the drug did not help the vast majority of patients enrolled in the trial, the doctors were encouraged by the outcome of one patient – a 73-year-old woman – whose condition radically improved.

View the original article here: Genome Sequencing of One Patient’s Tumor Could Lead to New …

Crop breeding consultant questions GM wheat report

A WA consultant in crop breeding and biotechnology has questioned the credibility of a report that suggests a variety of genetically modified wheat is potentially fatal. The report by a New Zealand genetics lecturer has found humans eating the CSIRO-developed grain could develop a glycogen storage disease which causes liver failure. The GM variety is being trialed in the ACT. The State Government says there are no plans at this stage to trial the crop in WA.

View the original article here: Crop breeding consultant questions GM wheat report

Genetics expert calls for fertility focus on cattle

A UNITED States cattle reproduction expert has urged Australian dairy farmers to take reproduction in their herds more seriously.

Charlie Perotti, who is a senior executive at Alta Genetics and manages the company’s global reproduction program, spoke at the recent Young Dairy Development Program’s ‘Milk it 4 More’ expo at Glenormiston.

He said poor fertility levels in Australian dairy cows should not be tolerated. “Farmers here have got to focus more on getting cows pregnant,” he said.

“There is just no excuse. Reproduction is the number one economic driver on a dairy farm.” He advised dairy farmers to adopt extensive synchronisation programs and regular pregnancy-checking protocols.

View the original article here: Genetics expert calls for fertility focus on cattle

GM rice is more than food for thought

The Ministry of Health’s investigation into a controversial US-backed genetically modified rice research project in Hunan province raises a wider set of questions than just the use of GM seeds to increase crop yields, because the researchers are alleged to have fed students GM rice as part of an experiment without their or their parents’ knowledge.

The research was backed by the US National Institute of Health and the US Department of Agriculture, according to an article published in the August edition of the Journal of Clinical Nutrition.

The answers to all the questions that the Ministry of Health-ordered investigation raises are not yet known. GM seed makers say there is no proof that their seeds will harm human health, but a host of geneticists and ecologists across the world say there is no proof that GM seeds will not harm humans.

View the original article here: GM rice is more than food for thought

Stem cells restore hearing in deaf gerbils

b x

In a new study, scientists were able to restore partial hearing to deaf gerbils by implanting human embryonic stem cells in their ears. The breakthrough offers hope that one day a similar treatment may be developed to cure hearing loss in humans.

One cause of hearing loss is auditory neuropathy, the impairment of auditory neurons that normally transmit sound signals from the ear to the brain. Researchers at the University of Sheffield in the UK sought to restore hearing in 18 gerbils whose auditory nerves had been experimentally damaged, by replacing the nerves with new ones derived from human embryonic stem cells.

View the original article here: Can You Hear Me Now? Stem Cells Restore Hearing In Deaf Gerbils – When … – Singularity Hub

GM crops a solution for improving crop yield, say experts

Genetically modified crops are an answer to improve crop yield and help maintain high food production, industry experts have said.

“In a country like India where resources are limited and the burden of the population is growing rapidly, a judicious use of plant biotechnology, after addressing the bio safety issues, can help farmers grow more food on the same amount of land,” Centre for Agricultural Bioscience International ( CABI) Regional Director ( South Asia) Ravi Khetrapal told PTI.

View the original article here: GM crops a solution for improving crop yield, say experts

Prenatal information: Ecstasy or agony?

Slate reposts a piece from New Scientist, Do You Really Want To Know Your Baby’s Genetics? It is arranged as a series of questions which might arise from the new information. For me my frustration with this sort of discussion is rooted in reviewing old articles about “test-tube babies” in major newspapers from the 1970s and early 1980s. Today in vitro fertilization is banal and commonplace, but many of the same concerns were voiced back then which you see cropping up now in regards to personal genomics. My issue is not concern as such, but its inchoate character. It is not uncommon for me to encounter people pursuing postgraduate work in science who express the opinion that “it’s scary,” the “it” being genetic information. When further queried the fear is generally layers upon layers of formless disquiet, some confusion about the specific details, as well as a default stance toward the “precautionary principle.”
With all due respect this isn’t rocket science. There’s no need to be overly general, the issues we’ll face are precise and specific, and often actually implicitly or explicitly enumerated in pieces such as the one above, which nevertheless manage to convey an air of murky foreboding. Unfortunately, not all of the issues are easily resolved, nor are they uncontroversial. For example I think abortion is actually a clear and distinct problem, because most of know where we stand on that. But what about the threshold for what constitutes a genetically normal individual? Frankly, most of us haven’t even really grappled with what that’s supposed to mean (to a great extent, I haven’t, and I probably think about these things more than the normal person). We marry, and we have children. So it’s been back to the dawn of time.

View the original article here: Prenatal information: Ecstasy or agony?

DNA methylation study finds key to bee destiny

New research published in the journal Nature Neuroscience on September 16, 2012, and reviewed at the Eureka Alert web site on the same day is the first to develop an understanding of behavior and the relationship of DNA methylation to behavioral change in bees.

Andy Feinberg, M.D., M.P.H., Gilman scholar, professor of molecular medicine and director of the Center for Epigenetics at Johns Hopkins‘ Institute for Basic Biomedical Sciences and Gro Amdam, Ph.D., associate professor of life sciences at Arizona State University and the Norwegian University of Life Sciences, analyzed the DNA methylation patterns in the brains of 21 bees using CHARM (comprehensive high-throughput arrays for relative methylation). CHARM allows the analysis of the entire genome at once.

View the original article here: DNA methylation study finds key to bee destiny

As drought hits corn, biotech firms see lush field in GMO crops

The worst U.S. drought in half a century is withering the nation’s corn crop, but it’s a fertile opportunity for makers of genetically modified crops.

Agricultural biotechnology companies have been pouring hundreds of millions of dollars into developing plants that can withstand the effects of a prolonged dry spell. Monsanto Co., based in St. Louis, has received regulatory approval for DroughtGard, a corn variety that contains the first genetically modified trait for drought resistance.

Seed makers, such as Pioneer Hi-Bred International Inc. of Johnston, Iowa, and Swiss company Syngenta, are already selling drought-tolerant corn varieties, conceived through conventional breeding.

At stake: a $12-billion U.S. seed market, with corn comprising the bulk of sales. The grain is used in such things as animal feed, ethanol and food. The push is also on to develop soybean, cotton and wheat that can thrive in a world that’s getting hotter and drier.

View the original article here: As drought hits corn, biotech firms see lush field in GMO crops